Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5190748
Max Phase: Preclinical
Molecular Formula: C33H55N2O10P
Molecular Weight: 670.78
Associated Items:
ID: ALA5190748
Max Phase: Preclinical
Molecular Formula: C33H55N2O10P
Molecular Weight: 670.78
Associated Items:
Canonical SMILES: CCCCCCCCCCCOc1cccc(CCC(=O)NC[C@@H](O)COP(=O)(O)OC[C@H](NC(=O)C2CCCCC2)C(=O)O)c1
Standard InChI: InChI=1S/C33H55N2O10P/c1-2-3-4-5-6-7-8-9-13-21-43-29-18-14-15-26(22-29)19-20-31(37)34-23-28(36)24-44-46(41,42)45-25-30(33(39)40)35-32(38)27-16-11-10-12-17-27/h14-15,18,22,27-28,30,36H,2-13,16-17,19-21,23-25H2,1H3,(H,34,37)(H,35,38)(H,39,40)(H,41,42)/t28-,30+/m1/s1
Standard InChI Key: VKFRLXHEIUAYBJ-DGPALRBDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 670.78 | Molecular Weight (Monoisotopic): 670.3594 | AlogP: 5.29 | #Rotatable Bonds: 25 |
Polar Surface Area: 180.72 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.89 | CX Basic pKa: | CX LogP: 5.51 | CX LogD: -0.12 |
Aromatic Rings: 1 | Heavy Atoms: 46 | QED Weighted: 0.07 | Np Likeness Score: -0.19 |
1. Sayama M, Uwamizu A, Ikubo M, Chen L, Yan G, Otani Y, Inoue A, Aoki J, Ohwada T.. (2021) Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine., 64 (14.0): [PMID:34233115] [10.1021/acs.jmedchem.1c00347] |
Source(1):